1. Home
  2. BSX vs PLD Comparison

BSX vs PLD Comparison

Compare BSX & PLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • PLD
  • Stock Information
  • Founded
  • BSX 1979
  • PLD 1983
  • Country
  • BSX United States
  • PLD United States
  • Employees
  • BSX N/A
  • PLD N/A
  • Industry
  • BSX Medical/Dental Instruments
  • PLD Real Estate Investment Trusts
  • Sector
  • BSX Health Care
  • PLD Real Estate
  • Exchange
  • BSX Nasdaq
  • PLD Nasdaq
  • Market Cap
  • BSX 120.7B
  • PLD 111.1B
  • IPO Year
  • BSX 1992
  • PLD 1994
  • Fundamental
  • Price
  • BSX $81.60
  • PLD $127.23
  • Analyst Decision
  • BSX Strong Buy
  • PLD Buy
  • Analyst Count
  • BSX 21
  • PLD 18
  • Target Price
  • BSX $85.24
  • PLD $133.22
  • AVG Volume (30 Days)
  • BSX 4.2M
  • PLD 2.5M
  • Earning Date
  • BSX 10-24-2024
  • PLD 10-15-2024
  • Dividend Yield
  • BSX N/A
  • PLD 3.02%
  • EPS Growth
  • BSX 104.77
  • PLD N/A
  • EPS
  • BSX 1.23
  • PLD 3.04
  • Revenue
  • BSX $15,229,000,000.00
  • PLD $8,104,101,000.00
  • Revenue This Year
  • BSX $15.45
  • PLD N/A
  • Revenue Next Year
  • BSX $10.88
  • PLD $8.71
  • P/E Ratio
  • BSX $66.48
  • PLD $41.75
  • Revenue Growth
  • BSX 13.65
  • PLD 1.01
  • 52 Week Low
  • BSX $48.35
  • PLD $96.64
  • 52 Week High
  • BSX $82.47
  • PLD $137.52
  • Technical
  • Relative Strength Index (RSI)
  • BSX 66.25
  • PLD 56.55
  • Support Level
  • BSX $80.50
  • PLD $124.64
  • Resistance Level
  • BSX $82.47
  • PLD $130.48
  • Average True Range (ATR)
  • BSX 1.12
  • PLD 2.33
  • MACD
  • BSX 0.25
  • PLD -0.09
  • Stochastic Oscillator
  • BSX 81.79
  • PLD 57.74

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About PLD Prologis Inc.

Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1.2 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $60 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.

Share on Social Networks: